NAKAJIMA Kei 中嶌圭

… Alternative Names

Nakajima Kei 中嶌圭

Less

Researcher Number	20447709
Other IDs
Affiliation (Current)	2025: 山梨大学, 大学院総合研究部, 助教
Affiliation (based on the past Project Information) *help	2024: 山梨大学, 大学院総合研究部, 臨床助教 2019 – 2022: 山梨大学, 大学院総合研究部, 臨床助教 2014: 山梨大学, 医学部附属病院, 医員 2012 – 2013: 山梨大学, 医学部附属病院, 助教
Review Section/Research Field	Principal Investigator Basic Section 54010:Hematology and medical oncology-related Except Principal Investigator Basic Section 54010:Hematology and medical oncology-related / Hematology
Keywords	Principal Investigator 抗がん剤耐性 / へキソキナーゼ / HIF / NF-kB / HexokinaseⅡ（HXKⅡ） / メトホルミン / ヘキソキナーーゼⅡ / NF-ｋB / SIRT1 / バーキットリンパ腫 … More / AMPK / NF-κB / ヘキソキナーゼ２ / 解糖系 / 悪性リンパ腫 … More Except Principal Investigator 骨髄増殖性腫瘍 / JAK2V617F / 組織因子 / GRP78 / 血栓 / 白血病 / TETファミリー / エピゲノム / JAK２変異 / 低酸素応答 / methylation / WNT5 / Hypoxia / Wnt5 / TET2 / hypoxia Less

GRP78の発現異常は骨髄増殖性腫瘍の血栓性病態を誘導するか？
- Principal Investigator
  
  桐戸敬太
- Project Period (FY)
  2024 – 2028
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  University of Yamanashi
Crosstalk between Glycolysis and NF-kappa B activation in malignant lymphoma cellsPrincipal Investigator
- Principal Investigator
  
  Nakajima Kei
- Project Period (FY)
  2019 – 2022
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  University of Yamanashi
Hypoxia modulate epigenomic response in MPN cells
- Principal Investigator
  
  KIRITO Keita
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  University of Yamanashi

All 2019 2015 2014 2013

All Journal Article

[Journal Article] Glycolytic enzyme hexokinase II is a putative therapeutic target in B-cell malignant lymphoma2019
- Author(s)
  Nakajima Kei、Kawashima Ichiro、Koshiisi Megumi、Kumagai Takuma、Suzuki Megumi、Suzuki Jun、Mitsumori Toru、Kirito Keita
- Journal Title
  
  Experimental Hematology
  
  Volume: 78 Pages: 46-55.e3
- DOI
  10.1016/j.exphem.2019.09.023
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K08319, KAKENHI-PROJECT-19K17826
[Journal Article] Negative regulation of the LKB1/AMPK pathway by ERK in human acute myeloid leukemia cells2015
- Author(s)
  Kawashima, I. Mitsumori, T. Nozaki, Y. Yamamoto, T. Shobu-Sueki, Y. Nakajima, K. Kirito, K.
- Journal Title
  
  Exp Hematol
  
  Volume: in press Issue: 7 Pages: 524-533.e1
- DOI
  10.1016/j.exphem.2015.03.005
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-24591386, KAKENHI-PROJECT-15K09470
[Journal Article] Anaplastic large cell lymphoma with paraneoplastic neutrophilia: an association between IL-17 elevation and aggressive disease progression.2014
- Author(s)
  Sueki Y, Nozaki Y, Kawashima I, Yamamoto T, Nakajima K, Mitumori T, Kirito K.
- Journal Title
  
  Int J Hematol
  
  Volume: in press
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591386
[Journal Article] Hypoxia inhibits JAK2V617F activation via suppression of SHP-2 function in myeloproliferative neoplasm cells2014
- Author(s)
  Mitsumori, T. Nozaki, Y. Kawashima, I. Yamamoto, T. Shobu, Y. Nakajima, K. Morishita, S. Komatsu, N. Kirito, K.
- Journal Title
  
  Exp Hematol
  
  Volume: 42 Issue: 9 Pages: 783-792.e1
- DOI
  10.1016/j.exphem.2014.05.007
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-24591386
[Journal Article] Rituximab activates Syk and AKT in CD20-positive B-cell lymphoma cells dependent on cell membrane cholesterol levels2013
- Author(s)
  Nozaki, Y. Mitumori, T. Yamamoto, T. Kawashima, I. Shobu, Y. Hamanaka, S. Nakajima, K. Komatsu, N. Kirito, K.
- Journal Title
  
  Experimental Hematology
  
  Volume: in press
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591386

1. KIRITO Keita (90306150)

# of Collaborated Projects: 2 results

# of Collaborated Products: 5 results
2. MITSUMORI Toru (80377514)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
3. NOZAKI Yumi (80530104)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
4. 川島一郎 (20622369)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results

NAKAJIMA Kei 中嶌 圭

Nakajima Kei 中嶌 圭

Research Projects

Research Products

Co-Researchers

GRP78の発現異常は骨髄増殖性腫瘍の血栓性病態を誘導するか？

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Crosstalk between Glycolysis and NF-kappa B activation in malignant lymphoma cellsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Hypoxia modulate epigenomic response in MPN cells

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Glycolytic enzyme hexokinase II is a putative therapeutic target in B-cell malignant lymphoma2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Negative regulation of the LKB1/AMPK pathway by ERK in human acute myeloid leukemia cells2015

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Anaplastic large cell lymphoma with paraneoplastic neutrophilia: an association between IL-17 elevation and aggressive disease progression.2014

Author(s)

Journal Title

Data Source

[Journal Article] Hypoxia inhibits JAK2V617F activation via suppression of SHP-2 function in myeloproliferative neoplasm cells2014

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Rituximab activates Syk and AKT in CD20-positive B-cell lymphoma cells dependent on cell membrane cholesterol levels2013

Author(s)

Journal Title

Data Source

NAKAJIMA Kei 中嶌圭

Nakajima Kei 中嶌圭